-
Original Article05-16-2019
Clinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil
- Adriana Yoshida
, - Bárbara Virginia Gonçalves Tavares,
- Luís Otavio Sarian,
- Liliana Aparecida Lucci Ângelo Andrade,
- Sophie Françoise Derchain
Abstract
Original ArticleClinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil
Revista Brasileira de Ginecologia e Obstetrícia. 2019;41(3):176-182
- Adriana Yoshida ,
- Bárbara Virginia Gonçalves Tavares,
- Luís Otavio Sarian,
- Liliana Aparecida Lucci Ângelo Andrade,
- Sophie Françoise Derchain
Views109See moreAbstract
Objective
The aim of the present study was to describe and analyze data of 57 women with borderline ovarian tumors (BOTs) regarding histological characteristics, clinical features and treatment management at the Department of Obstetrics and Gynecology of the Universidade Estadual de Campinas (Unicamp, in the Portuguese acronym).
Methods
The present retrospective study analyzed data obtained from clinical and histopathological reports of women with BOTs treated in a single cancer center between 2010 and 2018.
Results
A total of 57 women were included, with a mean age of 48.42 years old (15.43- 80.77), of which 30 (52.63%) were postmenopausal, and 18 (31.58%) were < 40 years old. All of the women underwent surgery. A total of 37 women (64.91%) were submitted to complete surgical staging for BOT, and none (0/57) were submitted to pelvic or paraortic lymphadenectomy. Chemotherapy was administered for two patients who recurred. The final histological diagnoses were: serous in 20 (35.09%) cases, mucinous in 26 (45.61%), seromucinous in 10 (17.54%), and endometrioid in 1 (1.75%) case. Intraoperative analyses of frozen sections were obtained in 42 (73.68%) women, of which 28 (66.67%) matched with the final diagnosis. The mean follow-up was of 42.79 months (range: 2.03-104.87 months). Regard ingthe current status of the women, 45(78.95%) are alive without disease, 2(3.51%) arealive with disease, 9 (15.79%) had their last follow-up visit > 1 year beforethe performanceof the present study but arealive, and 1 patient(1.75%) died of another cause.
Conclusion
Women in the present study were treated according to the current guidelines and only two patients recurred.
Views109
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract
Original ArticleClinical Features and Management of Women with Borderline Ovarian Tumors in a Single Center in Brazil
Revista Brasileira de Ginecologia e Obstetrícia. 2019;41(3):176-182
- Adriana Yoshida ,
- Bárbara Virginia Gonçalves Tavares,
- Luís Otavio Sarian,
- Liliana Aparecida Lucci Ângelo Andrade,
- Sophie Françoise Derchain
Views109See moreAbstract
Objective
The aim of the present study was to describe and analyze data of 57 women with borderline ovarian tumors (BOTs) regarding histological characteristics, clinical features and treatment management at the Department of Obstetrics and Gynecology of the Universidade Estadual de Campinas (Unicamp, in the Portuguese acronym).
Methods
The present retrospective study analyzed data obtained from clinical and histopathological reports of women with BOTs treated in a single cancer center between 2010 and 2018.
Results
A total of 57 women were included, with a mean age of 48.42 years old (15.43- 80.77), of which 30 (52.63%) were postmenopausal, and 18 (31.58%) were < 40 years old. All of the women underwent surgery. A total of 37 women (64.91%) were submitted to complete surgical staging for BOT, and none (0/57) were submitted to pelvic or paraortic lymphadenectomy. Chemotherapy was administered for two patients who recurred. The final histological diagnoses were: serous in 20 (35.09%) cases, mucinous in 26 (45.61%), seromucinous in 10 (17.54%), and endometrioid in 1 (1.75%) case. Intraoperative analyses of frozen sections were obtained in 42 (73.68%) women, of which 28 (66.67%) matched with the final diagnosis. The mean follow-up was of 42.79 months (range: 2.03-104.87 months). Regard ingthe current status of the women, 45(78.95%) are alive without disease, 2(3.51%) arealive with disease, 9 (15.79%) had their last follow-up visit > 1 year beforethe performanceof the present study but arealive, and 1 patient(1.75%) died of another cause.
Conclusion
Women in the present study were treated according to the current guidelines and only two patients recurred.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. - Adriana Yoshida
fertility sparing surgery Archives - Revista Brasileira de Ginecologia e Obstetrícia
